Role of naive and memory T cells in tumor cell lysis mediated by bi-specific antibodies

Immunobiology

Volumn 197, Issue 1, 1997, Pages 122-132

  Renner, Christoph ^a,b   Held, Gerhard ^a   Ohnesorge, Sascha ^a   Bauer, Stefan ^a   Gerlach, Klaus ^a   Pfitzenmeier, Jan Peter ^a   Pfreundschuh, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISPECIFIC ANTIBODY; CALCIUM ION; CD28 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; GRANZYME B; MESSENGER RNA; PERFORIN; TUMOR ANTIGEN;

ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOLYSIS; ENZYME INHIBITION; EXTRACELLULAR CALCIUM; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MEMORY CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TARGET CELL DESTRUCTION; TUMOR CELL;

EID: 0030861188     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(97)80062-9     Document Type: Article

References (34)

1. RENNER, C., and M. PFREUNDSCHUH. 1995. Tumor therapy by immune recruitment with bispecific antibodies. Immunol. Rev. 145: 179.
2. Milstein, C., and A. C. CUELLO. 1983. Hybrid hybridomas and their use in immunohistochemistry. Nature 305: 537.
3. STAERZ, U. D., and M. J. BEVAN. 1986. Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T cell activity. Proc. Natl. Acad. Sci. U.S.A. 83: 1453.
4. WEINER, G. J., and J. R. HILLSTROM. 1991. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma. J. Immunol. 147: 4035.
5. JUNG, G., J. A. LEDBETTER, and H. J. MULLER-EBEREHARD. 1987. Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates. Proc. Nat. Acad. Sci. U.S.A. 84: 4611.
6. RENNER, C., W. JUNG, U. SAHIN, R. DENFELD, C. POHL, L. TRUMPER, F. HARTMANN, V. DIEHL, R. VAN LIER, and M. PFREUNDSCHUH. 1994. Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells. Science 264: 833.
7. RENNER, C., ST. BAUER, U. SAHIN, W. JUNG, R. VAN LIER, G. JACOBS, G. HELD, and M. PFREUNDSCHUH. 1996. Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: The role of human T cell subsets in a preclinical model. Blood 87: 2930.
8. RENNER, C., W. JUNG, U. SAHIN, and M. PFREUNDSCHUH. 1996. The role of lymphocyte subsets and adhesion molecules in T cell dependent cytotoxicity mediated by CD3 and CD28 bispecific monoclonal antibodies. Eur. J. Immunol. 25: 2027.
9. BLOMBERG, K., and A. C. ULFSTEDT. 1993. Fluorescent europium chelates as target cell markers in the assessment of natural killer cell cytotoxicity. J. Immunol. Meth. 160: 27.
10. AZUMA, M., M. CAYABYAB, J. H. PHILLIPS, and L. LANIER. 1993. Requirement for CD28-dependent T cell-mediated cytotoxicity. J. Immunol. 150: 2091.
11. + lymphocytes. Eur. J. Immunol. 25: 644.
12. BEUN, G. D. M., A. GORTER, Y. NOOYEN, C. J. V. DE VELDE, and G. J. FLEUREN. 1993. T cell retargetuing using bispecific monoclonal antibodies in a rat colon carcinoma model. II. Syngeneic colon carcinoma CC531 is efficiently killed by retargeted cytotoxic T lymphocytes in vitro despite limited lysis in 51Cr release assays. J. Immunol. 150: 2305.
13. BEUN, G. D. M., J. H. V. DE VELDE, and G. J. FLEUREN. 1994. T cell based cancer immunotherapy: direct or redirected tumor-cell recognition? Immunol. Today 15: 11.
14. HOON, D. S. B., Y. HAYASHI, T. MORISAKI, L. J. FOSHAG, and D. L. MORTON. 1993. Interleukin-4 plus tumor necrosis factor augments the antigenicity of melanoma cells. Cancer Immunol. Immunother. 37: 378.
15. NAKAMURA, Y., H. WAKIMOTO, J. ABE, Y. KANEGAE, I. SAITO, M. AOYAGI, H. KIKIYOSHI, and H. HAMADA. 1994. Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2. Cancer Res. 54: 5757.
16. BERKE, G. 1995. The CTL's kiss of death. Cell 81: 9.
17. GRIFFITHS, G. M. 1995. The cell biology of CTL killing. Curr. Opin. Immunol. 7: 343.
18. LICHTENHELD, M. G., K. J. OLSEN, P. LU, D. M. LOWREY, A. HAMEED, H. HENGARTNER, and E. R. PODACK. 1989. Structure and function of human perforin. Nature 335: 448.
19. SHINKAI, Y., K. TAKIO, and K. OKUMURA. 1988. Homology of perforin to the ninth component of complement (C9). Nature 334: 525.
20. KÄGI, D., B. LEDERMANN, K. BÜRKI, P. SEILER, B. ODERMATT, K. J. OLSEN, E. R. PODACK, R. M. ZINKERNAGEL, and H. HENGARTNER. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369: 31.
21. WALSH, C. M., M. MALTOUBIAN, C. C. LIU, R. UEDA, C. G. KURAHARA, J. L. CHRISTENSEN, M. T. F. HUANG, J. D. E. YOUNG, R. AHMED, and W. R. CLARK. 1994. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. U.S.A. 91: 10854.
22. SHI, L., C. M. KAM, J. C. POWERS, R. AEGESOLD, and A. H. GREENBERG. 1992. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J. Exp. Med. 176: 1521.
23. NAKAJIMA, H., and P. A. HENKART. 1994. Cytotoxic lymphocyte granzymes trigger a target cell internal disintegration pathway leading to cytolysis and DNA breakdown. J. Immunol. 152: 1057.
24. RENNER, C., S. OHNSORGE, G. HELD, ST. BAUER, W. JUNG, J. P. PFITZENMEIER, and M. PFREUNDSCHUH. 1996. T cells from patients with Hodgkin's disease have a defective T cell receptor ζ-chain expression which is reversible by T cell stimulation with CD3 and CD28. Blood 88: 236.
25. SCHMID, I., C. H. UITTENBOGAART, B. KELD, and J. V. GIORGI. 1994. A rapid method for measuring apoptosis and dual color immunofluorescence by single laser flow cytometry. J. Immunol. Meth. 170: 145.
26. GOLD, R., M. SCHMIED, G. ROTHE, H. ZISCHLER, H. BREITSCHOPF, H. WEKERLE, and H. LASSMANN. 1993. Detection of DNA fragmentation in apoptosis: application of In Situ Nick Translation to cell culture systems and tissue sections. J. Histochem. Cytochem. 41: 1023.
27. MIGLIORATI, G., I. M. NICOLETTI, C. PAGLIACCI, L. D'ADAMIO, and C. RICCARDI. 1993. Interleukin-2 induces apoptosis in mouse thymocytes. Cell. Immunol. 146: 52.
28. 2+. Immunology 39: 109.
29. CHOMCZYNSKI, P., and N. SACCHI. 1987. Single-step method for RNA isolation by acid guanidmium thiocyanate-phenolchloroform extraction. Anal. Biochem. 612: 156.
30. 1 Lymphoma: Increased efficacy with multiple injections and CD28-induced costimulation. Blood 87: 4390.
31. NAKAJIMA, F., A. KHANNA, G. XU, M. LAGMAN, R. HASCHEMEYER, J. MOURADIAN, J. C. WANG, K. H. STENZEL, A. L. RUBIN, and M. SUTHANTHIRAN. 1994. immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: Stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression. Proc. Natl. Acad. Sci. U.S.A. 91: 7889.
32. LEGER-RAVET, M. B., O. DEVERNGE, M. PEUCHMAUR, P. SOLAL-CELIGNY, N. BROUSSE, P. CAULARD, P. GALANAUD, and D. EMILIE. 1994. In-situ detection of activated cytotoxic cells in follicular lymphomas. Am. J. Pathol. 144: 492.
33. LÈGER-RAVET, M. B., C. MATHIOT, A. PORTIER, M. BRANDELY, P. GALANAUD, P. FRIDMAN, and D. EMILIE. 1994. Increased expression of perforin and granzyme B genes in patients with metastatic melanoma treated with recombinant interleukin-2. Cancer Immunol. Immunother. 39: 53.
34. GRIFFITHS, G. M., R. NAMIKAWA, CH. MUELLER, C. C. LIU, J. D. E. YOUNG, M. BILLINGHAM, and I. WEISSMAN. 1991. Granzyme A and perforin as markers for rejection in cardiac transplantation. Eur. J. Immunol. 21: 687.